Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart Mann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The New Zealand Medical Journal|August 25, 2004
Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide auditChris Ellis, Greg Gamble, John French, et al.
The New Zealand Medical Journal|August 25, 2004
Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilitiesChris Ellis, Gerald Devlin, Philip Matsis, et al.
American Heart Journal|March 20, 2012
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAndrew Tonkin, David Hunt, Merryn Voysey, et al.
Heart, Lung & Circulation|November 19, 2017
All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome AuditChris J Ellis, Greg D Gamble, Michael J A Williams, et al.
European Heart Journal|October 3, 2009
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDavid C Burgess, David Hunt, Liping Li, et al.
The New Zealand Medical Journal|April 7, 2017
A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012John M Elliott, Tom Kai Ming Wang, Greg D Gamble, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The New Zealand Medical Journal|August 25, 2004
Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide auditChris Ellis, Greg Gamble, John French, et al.
The New Zealand Medical Journal|August 25, 2004
Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilitiesChris Ellis, Gerald Devlin, Philip Matsis, et al.
American Heart Journal|March 20, 2012
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAndrew Tonkin, David Hunt, Merryn Voysey, et al.
Heart, Lung & Circulation|November 19, 2017
All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome AuditChris J Ellis, Greg D Gamble, Michael J A Williams, et al.
European Heart Journal|October 3, 2009
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDavid C Burgess, David Hunt, Liping Li, et al.
The New Zealand Medical Journal|April 7, 2017
A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012John M Elliott, Tom Kai Ming Wang, Greg D Gamble, et al.
Pageof 3